Pax Financial Group, LLC Neurocrine Biosciences Inc Transaction History
Pax Financial Group, LLC
- $524 Million
- Q4 2024
A detailed history of Pax Financial Group, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Pax Financial Group, LLC holds 7,927 shares of NBIX stock, worth $905,739. This represents 0.21% of its overall portfolio holdings.
Number of Shares
7,927
Previous 8,208
3.42%
Holding current value
$905,739
Previous $944,000
14.62%
% of portfolio
0.21%
Previous 0.18%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
653Shares Held
96.5MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.62 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.16 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$559 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$345 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$290 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...